サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1760689

医薬品製造の世界市場レポート 2025年

Pharmaceutical Manufacturing Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
医薬品製造の世界市場レポート 2025年
出版日: 2025年07月01日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医薬品製造の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR10.2％で8,467億4,000万米ドルに成長します。予測期間中の成長は、個別化医療の台頭、高齢者人口の拡大、バイオシミラー需要の増加、現地製造に対する政府の支援、慢性疾患の有病率の増加などに起因すると考えられます。予測期間における主な動向としては、連続製造の進展、人工知能の統合、スマート製造技術の採用、生物製剤製造におけるイノベーション、研究開発効率の向上への注力などが挙げられます。

慢性疾患の有病率の増加は、今後数年間の医薬品製造市場の拡大を促進すると予想されます。慢性疾患は、一般的に徐々に発症し1年以上持続する長期的な健康状態であり、多くの場合、継続的な医療を必要としたり、日常生活に影響を与えたりします。慢性疾患の増加は、平均寿命の伸び、座りがちなライフスタイル、食生活の乱れなどが主な原因であり、長期的なヘルスケアソリューションや予防的な健康対策へのニーズが高まっています。医薬品製造は、必要不可欠な医薬品の安定供給を確保し、医薬品開発におけるイノベーションを促進し、効果的な長期治療に対する需要の高まりに応えることで、慢性疾患への対応に重要な役割を果たしています。例えば、2024年9月、英国の政府機関である国民保健サービス（NHS）は、35歳以上の成人の11％が進行性の慢性腎臓病を患っており、その有病率と重症度は年齢とともに増加していると報告しました。75歳以上では48％近くが何らかの形で腎臓病に罹患しており、36％がより重症です。このように、慢性疾患の有病率の増加が医薬品製造市場の成長を牽引しています。

医薬品製造市場の主要企業は、完全自動化RLT製造施設などの先進ソリューションの開発に注力しており、生産効率を高め、高品質な基準を確保し、標的がん治療に対する需要の高まりに対応しています。自動化されたRLT製造施設は、放射性リガンド療法の製造を最適化し合理化するために高度な自動化技術を利用し、一貫した効率的でスケーラブルな製造を保証します。例えば、2024年1月、スイスに本社を置く製薬会社ノバルティスAGは、インディアナポリスにある最先端の放射性リガンド治療薬（RLT）製造施設でプルビクトを製造する承認を米国食品医薬品局（FDA）から取得しました。この拡張により、PluvictoとLutatheraを含む放射性リガンド治療薬の生産能力が大幅に強化されます。この移転は、標的がん治療薬に対する世界の需要の高まりに対応し、世界の患者アクセスを向上させるというノバルティスの大きな戦略の一環です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の医薬品製造PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界の医薬品製造市場：成長率分析
  • 世界の医薬品製造市場の実績：規模と成長, 2019-2024
  • 世界の医薬品製造市場の予測：規模と成長, 2024-2029, 2034F
  • 世界の医薬品製造総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の医薬品製造市場：分子タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 生物製剤とバイオシミラー
  • 従来の薬剤
  • 世界の医薬品製造市場：剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 錠剤
  • カプセル
  • 注射剤
  • スプレー
  • 懸濁液
  • 粉末
  • その他の剤形
  • 世界の医薬品製造市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 経口
  • 外用
  • 非経口
  • 吸入
  • その他の投与経路
  • 世界の医薬品製造市場：治療領域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 心血管疾患（CVD）
  • 痛み
  • 糖尿病
  • がん
  • 呼吸器疾患
  • その他の病気
  • 世界の医薬品製造市場：販売チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 小売り
  • 非小売
  • 世界の医薬品製造市場、バイオ医薬品とバイオシミラー、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
  • モノクローナル抗体
  • ワクチン
  • 組み換えタンパク質
  • 細胞療法
  • 遺伝子治療
  • ホルモン
  • 血液および血漿製品
  • 世界の医薬品製造市場、従来型医薬品、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
  • 鎮痛剤
  • 解熱剤
  • 抗生物質
  • 抗ウイルス薬
  • 抗真菌薬
  • 降圧剤
  • 抗うつ薬
  • 抗糖尿病薬

第7章 地域別・国別分析

  • 世界の医薬品製造市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の医薬品製造市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 医薬品製造市場：競合情勢
  • 医薬品製造市場：企業プロファイル
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Sanofi SA
  • Bristol Myers Squibb Company
  • Thermo Fisher Scientific Inc.
  • AstraZeneca plc
  • Abbott Laboratories
  • Novartis AG
  • GlaxoSmithKline plc
  • Takeda Pharmaceuticals Inc.
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Novo Nordisk A/S
  • Lonza Group AG
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories
  • Cipla Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 医薬品製造市場2029：新たな機会を提供する国
  • 医薬品製造市場2029：新たな機会を提供するセグメント
  • 医薬品製造市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r35566

Pharmaceutical manufacturing is the industrial process of creating, producing, and packaging medications and medical products at scale, utilizing chemical synthesis, biological processing, and the formulation of active and inactive ingredients. This process is conducted under strict regulatory and quality control standards to ensure the safety, efficacy, consistency, and compliance of drugs intended for both human and veterinary use within global healthcare systems.

The primary molecule types in pharmaceutical manufacturing include biologics, biosimilars, and conventional drugs. Tablets are solid, flat medications containing a specific amount of active ingredients. Other formulations include capsules, injectables, sprays, suspensions, powders, and more, which are administered via various routes such as oral, topical, parenteral, inhalation, and others. Pharmaceutical manufacturing serves a wide range of therapy areas, including cardiovascular diseases (CVDs), pain management, diabetes, cancer, respiratory diseases, and more. These products are distributed through both retail and non-retail sales channels.

The pharmaceutical manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical manufacturing market statistics, including the pharmaceutical manufacturing industry's global market size, regional shares, competitors with an pharmaceutical manufacturing market share, detailed pharmaceutical manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical manufacturing industry. This pharmaceutical manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical manufacturing market size has grown rapidly in recent years. It will grow from $519.78 billion in 2024 to $573.95 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth during the historic period can be attributed to the increasing global disease burden, rising healthcare spending, growing demand for generic drugs, patent expirations of blockbuster drugs, and the expansion of pharmaceutical production capacity.

The pharmaceutical manufacturing market size is expected to see rapid growth in the next few years. It will grow to $846.74 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth during the forecast period can be attributed to the rise of personalized medicine, the expanding elderly population, increasing demand for biosimilars, government support for local manufacturing, and the growing prevalence of chronic diseases. Key trends in the forecast period include advancements in continuous manufacturing, the integration of artificial intelligence, the adoption of smart manufacturing technologies, innovations in biologics production, and a focus on improving research and development efficiency.

The growing prevalence of chronic diseases is expected to drive the expansion of the pharmaceutical manufacturing market in the coming years. Chronic diseases are long-term health conditions that typically develop gradually and persist for a year or more, often requiring ongoing medical care or impacting daily activities. The rise in chronic diseases is largely due to increasing life expectancy, sedentary lifestyles, and poor dietary habits, all contributing to a greater need for long-term healthcare solutions and preventive wellness measures. Pharmaceutical manufacturing plays a crucial role in addressing chronic diseases by ensuring a steady supply of essential medications, fostering innovation in drug development, and meeting the rising demand for effective long-term treatments. For example, in September 2024, the National Health Service (NHS), a UK government organization, reported that 11% of adults aged 35 and older have advanced chronic kidney disease, with the prevalence and severity increasing with age. Nearly 48% of individuals aged 75 and above suffer from some form of the disease, and 36% have more severe stages. Thus, the growing prevalence of chronic diseases is driving growth in the pharmaceutical manufacturing market.

Major companies in the pharmaceutical manufacturing market are concentrating on developing advanced solutions, such as fully automated RLT manufacturing facilities, to boost production efficiency, ensure high-quality standards, and address the rising demand for targeted cancer therapies. An automated RLT manufacturing facility utilizes advanced automation technologies to optimize and streamline the production of radioligand therapies, ensuring consistent, efficient, and scalable manufacturing. For example, in January 2024, Novartis AG, a Switzerland-based pharmaceutical company, received approval from the US Food and Drug Administration (FDA) to produce Pluvicto at a cutting-edge radioligand therapy (RLT) manufacturing facility in Indianapolis. This expansion will significantly enhance the production capacity for its radioligand therapy medicines, including Pluvicto and Lutathera. This move is part of Novartis' larger strategy to meet the growing global demand for targeted cancer therapies and improve patient access worldwide.

In December 2024, Novo Holdings A/S, a Denmark-based asset management company, acquired Catalent for $16.5 billion. This acquisition allows Novo Holdings to strengthen its position in the life sciences sector by leveraging Catalent's leading expertise in drug development, manufacturing, and clinical supply management. The move aims to accelerate growth, improve patient outcomes, and create sustainable value within the pharmaceutical and biotechnology industries. Catalent Inc. is a US-based pharmaceutical company that offers pharmaceutical manufacturing services.

Major players in the pharmaceutical manufacturing market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories, Cipla Limited, Samsung Biologics, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Lupin Limited, and Jubilant Pharmova Limited.

North America was the largest region in the pharmaceutical manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical manufacturing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical manufacturing market consists of revenues earned by entities by providing services such as contract manufacturing, formulation development, quality control and testing, and packaging and labeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical manufacturing market also includes sales of syrups, patch formulations, biologics, and antibiotics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Manufacturing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Molecule Type: Biologics And Biosimilars; Conventional Drugs
  • 2) By Formulation: Tablets; Capsules; Injectable; Sprays; Suspensions; Powders; Other Formulations
  • 3) By Route Of Administration: Oral; Topical; Parenteral; Inhalations; Other Route Of Administrations
  • 4) By Therapy Area: Cardiovascular Diseases (CVDs); Pain; Diabetes; Cancer; Respiratory Diseases; Other Diseases
  • 5) By Sales Channel: Retail; Non-retail
  • Subsegments:
  • 1) By Biologics And Biosimilars: Monoclonal Antibodies; Vaccines; Recombinant Proteins; Cell Therapies; Gene Therapies; Hormones; Blood And Plasma Products
  • 2) By Conventional Drugs: Analgesics; Antipyretics; Antibiotics; Antivirals; Antifungals; Antihypertensives; Antidepressants; Antidiabetics
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Manufacturing Market Characteristics

3. Pharmaceutical Manufacturing Market Trends And Strategies

4. Pharmaceutical Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmaceutical Manufacturing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pharmaceutical Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pharmaceutical Manufacturing Market Growth Rate Analysis
  • 5.4. Global Pharmaceutical Manufacturing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pharmaceutical Manufacturing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pharmaceutical Manufacturing Total Addressable Market (TAM)

6. Pharmaceutical Manufacturing Market Segmentation

  • 6.1. Global Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biologics And Biosimilars
  • Conventional Drugs
  • 6.2. Global Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tablets
  • Capsules
  • Injectable
  • Sprays
  • Suspensions
  • Powders
  • Other Formulations
  • 6.3. Global Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Topical
  • Parenteral
  • Inhalations
  • Other Route Of Administrations
  • 6.4. Global Pharmaceutical Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Diseases (CVDs)
  • Pain
  • Diabetes
  • Cancer
  • Respiratory Diseases
  • Other Diseases
  • 6.5. Global Pharmaceutical Manufacturing Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retail
  • Non-retail
  • 6.6. Global Pharmaceutical Manufacturing Market, Sub-Segmentation Of Biologics And Biosimilars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Proteins
  • Cell Therapies
  • Gene Therapies
  • Hormones
  • Blood And Plasma Products
  • 6.7. Global Pharmaceutical Manufacturing Market, Sub-Segmentation Of Conventional Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Analgesics
  • Antipyretics
  • Antibiotics
  • Antivirals
  • Antifungals
  • Antihypertensives
  • Antidepressants
  • Antidiabetics

7. Pharmaceutical Manufacturing Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pharmaceutical Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Manufacturing Market

  • 8.1. Asia-Pacific Pharmaceutical Manufacturing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Manufacturing Market

  • 9.1. China Pharmaceutical Manufacturing Market Overview
  • 9.2. China Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Manufacturing Market

  • 10.1. India Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Manufacturing Market

  • 11.1. Japan Pharmaceutical Manufacturing Market Overview
  • 11.2. Japan Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Manufacturing Market

  • 12.1. Australia Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Manufacturing Market

  • 13.1. Indonesia Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Manufacturing Market

  • 14.1. South Korea Pharmaceutical Manufacturing Market Overview
  • 14.2. South Korea Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Manufacturing Market

  • 15.1. Western Europe Pharmaceutical Manufacturing Market Overview
  • 15.2. Western Europe Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Manufacturing Market

  • 16.1. UK Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Manufacturing Market

  • 17.1. Germany Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Manufacturing Market

  • 18.1. France Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Manufacturing Market

  • 19.1. Italy Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Manufacturing Market

  • 20.1. Spain Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Manufacturing Market

  • 21.1. Eastern Europe Pharmaceutical Manufacturing Market Overview
  • 21.2. Eastern Europe Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Manufacturing Market

  • 22.1. Russia Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Manufacturing Market

  • 23.1. North America Pharmaceutical Manufacturing Market Overview
  • 23.2. North America Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Manufacturing Market

  • 24.1. USA Pharmaceutical Manufacturing Market Overview
  • 24.2. USA Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Manufacturing Market

  • 25.1. Canada Pharmaceutical Manufacturing Market Overview
  • 25.2. Canada Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Manufacturing Market

  • 26.1. South America Pharmaceutical Manufacturing Market Overview
  • 26.2. South America Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Manufacturing Market

  • 27.1. Brazil Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Manufacturing Market

  • 28.1. Middle East Pharmaceutical Manufacturing Market Overview
  • 28.2. Middle East Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Manufacturing Market

  • 29.1. Africa Pharmaceutical Manufacturing Market Overview
  • 29.2. Africa Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Manufacturing Market Competitive Landscape And Company Profiles

  • 30.1. Pharmaceutical Manufacturing Market Competitive Landscape
  • 30.2. Pharmaceutical Manufacturing Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Manufacturing Market Other Major And Innovative Companies

  • 31.1. Sanofi SA
  • 31.2. Bristol Myers Squibb Company
  • 31.3. Thermo Fisher Scientific Inc.
  • 31.4. AstraZeneca plc
  • 31.5. Abbott Laboratories
  • 31.6. Novartis AG
  • 31.7. GlaxoSmithKline plc
  • 31.8. Takeda Pharmaceuticals Inc.
  • 31.9. Eli Lilly and Company
  • 31.10. Gilead Sciences Inc.
  • 31.11. Novo Nordisk A/S
  • 31.12. Lonza Group AG
  • 31.13. Sun Pharmaceutical Industries Ltd.
  • 31.14. Dr. Reddy's Laboratories
  • 31.15. Cipla Limited

32. Global Pharmaceutical Manufacturing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Manufacturing Market

34. Recent Developments In The Pharmaceutical Manufacturing Market

35. Pharmaceutical Manufacturing Market High Potential Countries, Segments and Strategies

  • 35.1 Pharmaceutical Manufacturing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Pharmaceutical Manufacturing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Pharmaceutical Manufacturing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer